Condition

Resectable Hepatocellular Carcinoma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Resectable Hepatocellular Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in China (1), United States (1), Spain (1)). By phase: Early Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Resectable Hepatocellular Carcinoma clinical trials

StudyPhaseWhereStatusRegistered
THIO and Cadonilimab for Resectable Liver Cancer Early Phase 1 Dallas, Texas Recruiting Mar 3, 2026
Atezolizumab and Bevacizumab before and after surgery for resectable liver cancer Phase 2 Badalona, Barcelona and 11 other locations Recruiting Jun 13, 2025
Neoadjuvant triple therapy for liver cancer — Fuzhou, Fujian and 5 other locations Recruiting Aug 26, 2024

All recruiting trials (3)

Related topics

CadonilimabAtezolizumabBevacizumabLenvatinib

Quick answers

How many Resectable Hepatocellular Carcinoma clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (1 trial), United States (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.